CD63 and bronchopulmonary dysplasia: In the present study, we evaluated this hypothesis by comparing peripheral platelet count, circulating MK count, platelet-activating markers, (CD62P and CD63) 28 days after birth in two groups, and the relationship between TPO expression and platelet count in infants with BPD.